Blue Current is a Hayward, California solid-state battery developer building what it calls a 'silicon-first,' fully dry battery platform. Its Silicon Elastic Composite chemistry ties glass-ceramic electrolyte particles to silicon anode particles with compliant polymers, constraining silicon swelling so high-silicon cells can cycle stably at low pressure without flammable liquids or PFAS. Positioned as a safety-focused, B2B licensing and pilot-manufacturing company, Blue Current targets electric mobility, grid-scale storage, and consumer devices, and closed an $80M+ Series D extension led by Amazon in December 2025.
Aqtual, Inc. is a Hayward, California precision medicine company that reads epigenetics, gene regulation and transcriptomics from a single blood draw. Its proprietary active-chromatin cell-free DNA (cfDNA) platform captures circulating chromatin to survey hundreds of thousands of regulatory sites, integrating DNA, epigenetic regulation and protein-DNA binding in one blood-based assay. The company is first commercializing a test that predicts which therapy will work for rheumatoid arthritis patients, with a broader pipeline spanning oncology, immunology, cardiovascular, metabolic and neurological disease. Aqtual has raised roughly $47M to date, including a $31M Series B in July 2025.